Defunct Company
Total Trials
25
As Lead Sponsor
20
As Collaborator
5
Total Enrollment
4,382
NCT00189306
Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream
Phase: Phase 3
Role: Lead Sponsor
Start: Mar 31, 2001
Completion: Apr 30, 2007
NCT00335179
Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream
Phase: Phase 2
Start: Jan 31, 2003
Completion: Jul 31, 2003
NCT00129519
A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence
Start: Jan 31, 2004
Completion: Jan 31, 2006
NCT00114920
Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults
Start: Mar 31, 2004
Completion: Not specified
NCT00115141
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults
Start: Apr 30, 2004
NCT00117923
Study With a Topical Gel to Treat Common Warts in Adults
Start: Aug 31, 2004
NCT00117871
Start: Oct 31, 2004
NCT00114023
1-Year Follow up to the 1473-IMIQ Study
Phase: N/A
Start: Jan 31, 2005
NCT00116662
An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
Start: Mar 31, 2005
NCT00116675
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
Completion: Apr 30, 2006
NCT00601016
A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy
Role: Collaborator
Completion: Sep 30, 2006
NCT00115154
Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands
Phase: Phase 4
Start: May 31, 2005
NCT00114673
A Study to Validate Cosmetic Outcome Scales Used to Rate Uneven Skin Color and Wrinkling
Start: Jun 30, 2005
NCT00116649
Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis
Completion: May 31, 2007
NCT00603798
Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)
Start: Jan 31, 2008
Completion: Jul 31, 2008
NCT00605176
Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)
NCT00638651
Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal
Phase: Phase 1
Start: Feb 29, 2008
Completion: Aug 31, 2014
NCT00668733
Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year
Start: Apr 30, 2008
Completion: Jul 31, 2009
NCT00674739
Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts
Start: May 31, 2008
NCT00735462
Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts
Start: Aug 31, 2008
NCT00979550
The Effects of Aldara as an Adjunct to Laser Treatment
Start: Oct 31, 2008
Completion: Aug 31, 2013
NCT00894647
Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery
Start: May 31, 2009
Completion: Feb 28, 2010
NCT01055106
Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis
Start: Jan 31, 2010
Completion: Apr 30, 2010
NCT01203878
Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
Start: Sep 30, 2010
Completion: Nov 30, 2011
NCT01229319
Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses
Start: Oct 31, 2010
Completion: Aug 31, 2011